Skip to main content Skip to navigation

News & Updates

TEAMM Updates


The TEAMM trial results were presented at The American Society of Haematology Conference in December 2017.

Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients:

Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients:

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy, Implication for Patient Management:

Myeloma UK:


Thank you to all of the patients and hospitals that took part in the trial.



Any enquiries please email

teamm at warwick dot ac dot uk